Securitize adds former IMF director Sunil Sabharwal to board

Securitize, Inc. appointed Sunil Sabharwal to its board of directors, the company announced. Sabharwal previously served as United States Alternate Executive Director at the International Monetary Fund and brings experience from financial services and payments companies.

Sabharwal currently serves on boards of Thunes and Tookitaki and advises Blackstone Growth Equity Fund. He previously served as chairman of Earthport, which Visa acquired, and chairman of Ogone, later acquired by Ingenico. Earlier roles included positions at GE Capital and First Data Corporation.

During his IMF tenure, a Senate-confirmed position spanning two administrations, Sabharwal represented U.S. interests on global financial policy and received the U.S. Treasury's Distinguished Service Award.

"Tokenization represents a fundamental evolution in how financial markets operate globally, enabling access to a wider range of investors," Sabharwal said. "Securitize is at the forefront of that transformation, bringing together regulatory rigor, institutional credibility, and cutting-edge technology."

Securitize operates a tokenization platform for real-world assets and reports $4 billion in assets under management as of April 2026. The company works with asset managers including Apollo, BlackRock, BNY, Hamilton Lane, KKR, and VanEck.

In the U.S., Securitize operates through SEC-registered affiliates including a broker-dealer with an Alternative Trading System and a transfer agent. In Europe, the company operates through Securitize Europe Brokerage and Markets, which holds authorization as an Investment Firm under the EU DLT Pilot Regime.

Securitize announced a proposed business combination with Cantor Equity Partners II, Inc. (NASDAQ: CEPT) in October 2025. The combined company expects to list on NYSE or Nasdaq under ticker "SECZ" in the first half of 2026, subject to regulatory approvals and shareholder approval.

You May Also Be Interested In

• Activist Jana Partners takes 6.3% stake in Alkami Technology, urges sale
• Curbline Properties prices 10M share offering at ~$308.5M
• FDA approves Arcutis' roflumilast cream for plaque psoriasis in children 2+